MedTrace Logo

PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation

NCT03933774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-08-18

Study results available
· View outcomes & findings →

Summary

A randomized controlled split-face pilot study was planned to investigate the preventive effect of tretinoin 0.05% cream on hyperpigmentation during phototherapy in patients with vitiligo.

Conditions

  • Vitiligo

Interventions

DRUG

Tretinoin 0.05% cream

Stieva-A Cream 0.05%, 25g, GSK

DRUG

Placebo cream

Physiogel Daily Mositure Therapy Facial cream, 150mL, Stiefel

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Principal Investigators

  • Jung Min Bae, MD, PhD · Department of Dermatology, College of Medicine, Catholic University of Korea

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-29
Primary Completion
2019-11-19
Completion
2019-11-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933774 on ClinicalTrials.gov